Researchers studied twenty patients with HPV-positive oropharyngeal cancer who underwent chemoradiotherapy. The team measured changes in physical fitness, body weight, and overall health status before treatment and at two and eight weeks after. They found that oxygen consumption at the anaerobic threshold dropped from 16.0 to 12.0 ml/kg/min by the two-week mark. This decline in peak oxygen use continued to be impaired at the eight-week follow-up. Alongside reduced fitness, patients also lost body mass and fat-free muscle mass, while grip strength decreased by an average of 4.1 kg.
Patients also reported worsening global health status and significantly higher levels of fatigue, which increased by nearly 50 points on average. These physical and functional changes were observed in both women and men within this small group. The study highlights that treatment-related side effects can persist for months after the initial therapy ends. Readers should understand that while these findings are concerning, they come from a single-arm design with very few participants.
This is the first study to estimate the impact of this treatment on cardiopulmonary fitness in this specific cancer group. However, the small sample size limits how widely these results can be applied to other patients. Further research is needed to confirm these effects and to develop targeted interventions that can help mitigate these adverse physiological changes. Until more data is available, these results should be viewed as an early signal rather than a definitive rule for all patients.